Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma
Pre-publication versions of this article are available by contacting email@example.com.
|7 Jun 2016||Submitted||Original manuscript|
|21 Nov 2016||Reviewed||Reviewer Report - Wei-Lien Wang|
|30 Dec 2016||Reviewed||Reviewer Report - Nicolaus Friedrichs|
|2 Jan 2017||Reviewed||Reviewer Report - Robin Lewis Jones|
|23 Feb 2017||Author responded||Author comments - Shutaro Yamada|
|Resubmission - Version 2|
|23 Feb 2017||Submitted||Manuscript version 2|
|28 Mar 2017||Reviewed||Reviewer Report - Wei-Lien Wang|
|31 Mar 2017||Reviewed||Reviewer Report - Nicolaus Friedrichs|
|27 Apr 2017||Author responded||Author comments - Shutaro Yamada|
|Resubmission - Version 3|
|27 Apr 2017||Submitted||Manuscript version 3|
|4 May 2017||Editorially accepted|
|16 May 2017||Article published||10.1186/s12885-017-3324-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.